Structural and Functional Diversities of the Hexadecahydro‐1H‐cyclopenta[a]phenanthrene Framework, a Ubiquitous Scaffold in Steroidal Hormones

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Informatics

• Publication date

  2016-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/minf.201600005PMID 27491924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards the Bioassay Activity Landscape Modeling in Compound Databases

  2017cited by this paper
• Specificity Rendering ‘Hot-Spots’ for Aurora Kinase Inhibitor Design: The Role of Non-Covalent Interactions and Conformational Transitions

  2014cited by this paper
• A facile access to novel steroidal 17-2'-(1',3',4')-oxadiazoles, and an evaluation of their cytotoxic activities in vitro.

  2014cited by this paper
• Rational approaches towards lead optimization of kinase inhibitors: the issue of specificity.

  2013cited by this paper
• Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.

  2013cited by this paper
• Data Mining of Protein-Binding Profiling Data Identifies Structural Modifications that Distinguish Selective and Promiscuous Compounds

  2012cited by this paper
• Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Interrogating Novel Areas of Chemical Space for Drug Discovery using Chemoinformatics

  2012cited by this paper
• Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma.

  2011cited by this paper
• Virtual high throughput screening in new lead identification.

  2011cited by this paper
• Steroid hormones as bactericidal agents to Helicobacter pylori.

  2011cited by this paper
• Characteristics of known drug space. Natural products, their derivatives and synthetic drugs.

  2010cited by this paper
• D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: Synthesis and biological evaluation.

  2010cited by this paper
• Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles

  2010cited by this paper
• Privileged scaffolds for library design and drug discovery.

  2010cited by this paper
• Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository

  2009cited by this paper
• Steroid Hormone Transforming Aldo‐Keto Reductases and Cancer

  2009cited by this paper
• Subtype selectivity in phosphodiesterase 4 (PDE4): a bottleneck in rational drug design.

  2008cited by this paper
• Natural products as leads to potential drugs: an old process or the new hope for drug discovery?

  2008cited by this paper
• Protein ligand interaction database (PLID)

  2008cited by this paper
• Scaffold diversity of natural products: inspiration for combinatorial library design.

  2008cited by this paper
• Natural products in drug discovery.

  2008cited by this paper
• The impact of natural products upon modern drug discovery.

  2008cited by this paper
• Efficient total synthesis of novel bioactive microbial metabolites.

  2008cited by this paper
• Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides

  2007cited by this paper
• Parallel synthesis and SAR study of novel oxa-steroids as potent and selective progesterone receptor antagonists.

  2007cited by this paper
• Synthesis of flavonoid analogues as scaffolds for natural product-based combinatorial libraries.

  2007cited by this paper
• Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists.

  2007cited by this paper
• Cardiotonic steroids on the road to anti-cancer therapy.

  2007cited by this paper
• Virtual screening in drug discovery -- a computational perspective.

  2007cited by this paper
• Small molecule natural products in the discovery of therapeutic agents: the synthesis connection.

  2006cited by this paper
• PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

  2006cited by this paper
• On scaffolds and hopping in medicinal chemistry.

  2006cited by this paper
• DrugBank: a comprehensive resource for in silico drug discovery and exploration

  2005cited by this paper
• Natural products to drugs: natural product derived compounds in clinical trials.

  2005cited by this paper
• ZINC - A Free Database of Commercially Available Compounds for Virtual Screening

  2005cited by this paper
• Natural products and combinatorial chemistry: back to the future.

  2004cited by this paper
• Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications.

  2003cited by this paper
• Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry

  2003cited by this paper
• Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria.

  2001cited by this paper
• Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.

  2001cited by this paper
• Parallel modification of tropane alkaloids

  2001cited by this paper
• Biocatalytic modification of natural products.

  2001cited by this paper
• Strategies for discovering drugs from previously unexplored natural products.

  2000cited by this paper
• The influence of natural products upon drug discovery.

  2000cited by this paper
• ICI 182,780 (Faslodex™)

  2000cited by this paper
• Combinatorial chemistry of natural products: Solid phase synthesis of D- and L-cycloserine derivatives

  1998cited by this paper
• Recent natural products based drug development: a pharmaceutical industry perspective.

  1998cited by this paper
• Combinatorial modification of natural products: preparation of unencoded and encoded libraries of Rauwolfia alkaloids.

  1996cited by this paper
• Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.

  1996cited by this paper
• Textbook of Endocrine Physiology

  1994cited by this paper
• Outer membranes of Gram‐negative bacteria are permeable to steroid probes

  1992cited by this paper
• Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.

  1991cited by this paper
• Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

  1990cited by this paper
• Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

  1988cited by this paper
• Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon.

  1985cited by this paper
• Steroid hormones.

  1978cited by this paper
• Book Review: Molecular Endocrinology of the Steroid Hormones

  1977cited by this paper

• The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives

  2023cites this paper
• Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite

  2022cites this paper
• Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods

  2022cites this paper
• Identification of unique subtype-specific interaction features in Class II zinc-dependent HDAC subtype binding pockets: A computational study

  2021cites this paper
• Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against SARS-Cov2-Envelope protein: A molecular dynamics investigation

  2020cites this paper
• Hybrid Pharmacophore Approach as a Novel Strategy to identify Anti-Mycobacterial Chemotypes: Investigation with DapB Enzyme

  2020cites this paper
• Hybrid Dynamic Pharmacophore Models as Effective Tools to Identify Novel Chemotypes for Anti-TB Inhibitor Design: A Case Study With Mtb-DapB

  2020cites this paper
• Data Science Driven Drug Repurposing for Metabolic Disorders

  2019cites this paper
• Pharmacophore Modelling and Screening: Concepts, Recent Developments and Applications in Rational Drug Design

  2019cites this paper
• Modeling the permeability of drug-like molecules through the cell wall of Mycobacterium tuberculosis: an analogue based approach.

  2016cites this paper